DeepIntent builds a healthcare-focused demand-side platform that lets pharmaceutical brands and healthcare agencies plan, activate, and optimize programmatic advertising using privacy-safe clinical and identity data. The company generates revenue from platform and media-buying fees across display, video, CTV, and mobile channels. Founded in 2016 and headquartered in New York, DeepIntent is backed by private equity firm Vitruvian Partners.